US Patent

US9044402 — Abuse-deterrent pharmaceutical compositions for controlled release

Method of Use · Assigned to Egalet Ltd · Expires 2033-07-01 · 7y remaining

Vulnerability score 62/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects pharmaceutical compositions that are abuse-resistant and provide controlled release for the treatment of pain.

USPTO Abstract

The present disclosure relates to pharmaceutical compositions that are abuse resistant and may also provide controlled release. The present disclosure also relates to the use of pharmaceutical compositions in the treatment of pain.

Drugs covered by this patent

chembl-chembl2103744 (MORPHINE SULFATE)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-1556`	—	chembl-chembl2103744
`U-1556`	—	chembl-chembl2103744
`U-1556`	—	chembl-chembl2103744

Patent Metadata

Patent number: US9044402
Jurisdiction: US
Classification: Method of Use
Expires: 2033-07-01
Drug substance claim: No
Drug product claim: Yes
Assignee: Egalet Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.